Kos Biotechnology Partners Announces Investment in Fathom Therapeutics to Advance Novel, AI-Driven Drug Discovery Platform

- Kos joins Sutter Hill Ventures and other leading investors in backing Fathom Therapeutics's pioneering physics- and AI-powered drug discovery platform

PR Newswire Business Technology · 2026-11-06T11:00:00.000Z